What is VascVersa?
VascVersa is a nascent Regenerative Medicine company recently established from Queen's University in Belfast. The company is focused on developing innovative solutions within the rapidly evolving field of regenerative therapies, positioning itself for significant growth and impact.
How much funding has VascVersa raised?
VascVersa has raised a total of $604K across 1 funding round:
Angel/Seed
$604K
Angel/Seed (2022): $604K with participation from Innovative Investments Capital Funding Group
Key Investors in VascVersa
Innovative Investments Capital Funding Group
Innovative Investments Capital Funding Group is a buy-and-hold group focused on real estate, aiming to keep people in their homes with a low foreclosure rate. They are seeking to purchase single homes and small pools of up to 40 homes nationwide.
What's next for VascVersa?
The recent major strategic investment signals a pivotal moment for VascVersa, likely enabling the company to accelerate its research and development initiatives, scale operations, and potentially pursue clinical trials. This infusion of capital is expected to fuel its trajectory in the competitive regenerative medicine landscape.
See full VascVersa company page
